Skip to content

The effect of exercise therapy in patients with thumb base osteoarthritis

The effect of Hand Therapy in patients with thumb base osteoarthritis: a prospective cohort study with propensity score matching

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21555
Enrollment
148
Registered
2015-12-22
Start date
2015-10-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thumb base osteoarthritis, CMC-1 OA, duimbasis artrose, basal joint arthritis

Interventions

Exercise therapy and splinting is compared with splinting alone

Sponsors

- Erasmus Medical Center Rotterdam - Handtherapie Nederland B.V. - Xpert Clinic Nederland
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Male/female and diagnosed with CMC-1 OA by the hand surgeon. The hand surgeon follows the guideline of the Dutch Society for Hand Surgery in the diagnostic process.15 - Eaton-Glickel20 stage I-IV - Age ≥18

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Secondary basal joint arthritis (i.e. due to Bennet fracture) - Comorbidities that may interfere with treatment/ bias outcome (i.e. rheumatoid arthritis, carpal tunnel syndrome, Quervain tenosynovitis) - Patient history includes surgery that may interfere with treatment/ bias outcome - Steroid injection <6 weeks in hand or wrist

Design outcomes

Primary

MeasureTime frame
- Pain intensity - Limitations in activities of daily life - Pinch & grip strength

Secondary

MeasureTime frame
- Return to work - Patient satisfaction - Secondary treatment

Contacts

Public ContactRobbert Wouters
robbertwouters@gmail.com06-53531875

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)